Plasma concentrations of tumour necrosis factor-α and interleukin-6 during burn wound surgery or dressing

British Journal of Plastic Surgery

Volumn 50, Issue 5, 1997, Pages 354-361

  Papini, R P ^a,c   Wilson, A P R ^a,c   Steer, J A ^a,c   Hill, G ^a   McGrouther, D A ^a,c   Parkhouse, N ^b,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d QUEEN VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYTOKINE; INTERLEUKIN 6; TEICOPLANIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BURN; BURN EXCISION; BURN INFECTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DETERIORATION; DOUBLE BLIND PROCEDURE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WOUND DRESSING;

EID: 0030822821     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0007-1226(97)90545-2     Document Type: Article

References (33)

1. Sasaki TM, Welch GW, Herndon DN, Kaplan JZ, Lindberg RB, Pruitt BA. Burn wound manipulation-induced bacteraemia. J Trauma 1979; 19: 46-8.
2. Petersen SR, Umphred E, Warden GD. The incidence of bacteraemia following burn wound excision. J Trauma 1982; 22: 274-9.
3. Piel P, Scarnati S, Goldfarb IW, Slater H. Antibiotic prophylaxis in patients undergoing burn wound excision. J Burn Care Rehabil 1985; 6: 422-4.
4. Papini RPG, Wilson APR, Steer JA, McGrouther DA, Parkhouse N. Wound management in burn centres in the United Kingdom. Br J Surg 1995; 82: 505-9.
5. Rackow EC, Astiz ME. Pathophysiology and treatment of septic shock. JAMA 1991; 266: 548-54.
6. Damas P, Reuter A, Gysen P, Demonty J, Lainy M, Franchimont P. Tumour necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17: 975-8.
7. Hack E, deGroot E, Felt-Bersma RJF, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74: 1704-10.
8. Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215: 356-62.
9. Dofferhoff ASM, Bom VJJ, de Vries-Hospers HG, et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992; 20: 185-92.
10. Fong Y, Lowry SF. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol 1990: 55: 157-70.
11. Steer JA, Papini RPG, Wilson APR, McGrouther DA, Nakhla LS, Parkhouse N. A randomized placebo controlled trial of teicoplanin in the antibiotic prophylaxis of infection following manipulation of burn wounds. Br J Surg 1997; in press.
12. Steer JA, Papini RPG, Wilson APR, McGrouther DA, Parkhouse N. Quantitative microbiology in the management of burn patients. I. Correlation between quantitative and qualitative burn wound biopsy culture and surface alginate swab culture. Burns 1996; 22: 173-6.
13. Steer JA, Papini RPG, Wilson APR, McGrouther DA, Parkhouse N. Quantitative microbiology in the management of burn patients. II. Relationship between bacterial counts obtained by burn wound biopsy culture and surface alginate swab culture, with clinical outcome following burn surgery and change of dressings. Burns 1996; 22: 177-81.
14. Gardner MJ, Altman DG. Statistics with confidence. London: British Medical Journal, 1989: 20-7.
15. Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Oxford: Blackwell, 1987: 296-357.
16. Foca A, Matera G, Berlinghieri MC. Inhibition of endotoxin-induced interleukin-8 release by teicoplanin in human whole blood. Eur J Clin Microbiol Infect Dis 1993; 12: 940-4.
17. Marano MA, Fong Y, Moldawer LL, et al. Serum cachectin/ TNF in critically ill burn patients correlates with infection and mortality. Surg Gynecol Obstet 1990; 170: 32-8.
18. Cannon JG, Friedberg JS, Gelfand JA, Tompkins RG, Burke JF, Dinarello CA. Circulating interleukin-1 βand tumor necrosis factor-α concentrations after burn injury in humans. Crit Care Med 1992; 20: 1414-19.
19. Endo S, Inada K, Yamada Y, et al. Plasma tumour necrosis factor-α (TNF-α) levels in patients with burns. Burns 1993; 19: 124-7.
20. Drost AC, Burleson DG, Cioffi WG, Mason AD, Pruitt BA. Plasma cytokines after thermal injury and their relationship to infection. Ann Surg 1993; 218: 74-8.
21. de Bandt JP, Chollet Martin S, Hernvann A, et al. Cytokine response to burn injury: relationship with protein metabolism. J Trauma 1994; 36: 624-8.
22. Marano M, Moldawer LL, Fong Y, et al. Cachectin/TNF production in experimental burns and Pseudomonas infection. Arch Surg 1988; 123: 1383-93.
23. Pruitt BA, Foley FD: The use of biopsies in burn patient care. Surgery 1973; 73: 887-97.
24. McManus AT, Kim SH, McManus WF, Mason AD, Pruitt BA. Comparison of quantitative microbiology and histopathology in divided burn-wound biopsy specimens. Arch Surg 1987; 122: 74-6.
25. Taddonio TE, Thomson PD, Smith DJ, Prasad JK. A survey of wound monitoring and topical antimicrobial therapy practices in the treatment of burn injury. J Burn Care Rehabil 1990; 11: 423-7.
26. Pos O, van der Stelt ME, Wolbink GJ, Nijsten MWN, van der Tempel GL, van Dijk W. Changes in the serum concentration and the glycosylation of human α1-acid glycoprotein and α1-protease inhibitor in severely burned persons: relation to interleukin-6 levels. Clin Exp Immunol 1990; 82: 579-82.
27. Guo Y, Dickerson C, Chrest FJ, Adler WH, Munster AM, Winchurch RA. Increased levels of circulating interleukin-6 in burn patients. Clin Immunol Immunopathol 1990; 54: 361-71.
28. Nijsten MWN, de Groot ER, ten Duis HJ, Klasen HJ, Hack CE, Aarden LA. Serum levels of interleukin-6 and acute phase responses (letter). Lancet 1987; ii: 921.
29. Kowal-Vern A, Walenga JM, Hoppensteadt D, Sharp-Pucci M, Gamelli RL. Interleukin-2 and interleukin-6 in relation to burn wound size in the acute phase of thermal injury. J Am Coll Surg 1994; 178: 357-62.
30. Ueyama M, Maruyama I, Osame M, Sawada Y. Marked increase in plasma interleukin-6 in burn patients. J Lab Clin Med 1992; 120: 693-8.
31. Rodriguez JL, Miller CG, Garner WL, et al. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993; 34: 684-95.
32. Nijsten MWN, Hack CE, Helle M, ten Duis HJ, Klasen HJ, Aarden LA. Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery 1991; 109: 761-7.
33. Shehab El-Din SA, Aref S, Salama OS, Shouman OM. Serum cytokines following thermal injury. Ann Burns Fire Disasters 1996; 9: 18-22.